Phase I–IV vaccine clinical trials and national immunization campaigns demand an uncompromising level of consumable precision, batch-to-batch consistency, and audit-proof regulatory traceability. In Good Clinical Practice (GCP) research, a single syringe dead-space variance or plunger sticking defect can alter pharmacokinetics, invalidate dosing data, or compromise patient safety. Vaccine sponsors and contract research organizations (CROs) across Europe, the US, and Asia often pay hefty premiums for legacy Western brands like BD SoloShot. Sourcing WHO-PQS and ISO 7886-3 compliant Auto-Disable (AD) syringes directly from audited Indian manufacturing cleanrooms ensures zero dosing variance, strict tamper-proof lockouts, and multi-lingual trial packaging at factory gate pricing.
A regulatory and procurement guide for CROs, pharmaceutical sponsors, and immunization ministries sourcing Auto-Disable (AD) syringes, batch-traceable clinical trial packs, and zero-defect single-use consumables from certified Indian facilities.
Auto-Disable (AD) syringes automatically lock or break their internal plunger mechanism upon completing a single full injection stroke, rendering re-use mechanically impossible and eliminating cross-contamination in high-throughput trial cohorts.
Immunization protocols require specific mechanical lockout designs to satisfy global health standards:
| Specification Parameter | Fixed-Needle AD Syringe (0.5ml) | Luer Lock Safety Syringe (1ml) | Standard Hypodermic Syringe | Clinical Trial Significance |
|---|---|---|---|---|
| Lockout Mechanism | Internal metal clip locks plunger permanently at end of forward stroke | Active manual safety shield clicks over needle post-injection | None (reusable plunger) | AD mechanism prevents intentional or accidental trial subject re-injection |
| Residual Dead Space Volume | < 0.002 ml (fixed needle directly into barrel) | < 0.025 ml | 0.050 – 0.075 ml | Eliminates expensive trial vaccine wastage (saving up to 2 extra doses per 10-dose vial) |
| Needle Gauge & Length | 23G x 1" or 24G x 1" (fixed) | Interchangeable luer hub | Interchangeable luer hub | Fixed needle prevents accidental needle detachment during rapid field trials |
| Manshav Impex Direct Factory Price | $0.042 – $0.058 per unit | $0.065 – $0.095 per unit | $0.032 – $0.045 per unit | 50% to 70% savings compared to legacy vaccine supply brands |
Clinical trial auditors mandate rigorous batch documentation before trial site clearance. Manshav Impex provides:
All our clinical trial syringes and packaging undergo low-temperature storage validation down to -20°C and -80°C, ensuring blister seals and polypropylene barrels do not crack or become brittle during frozen vaccine storage.
Yes. Our AD syringes are engineered to comply with WHO Performance, Quality and Safety (PQS) specifications and ISO 7886-3 requirements for single-use immunization devices.
We offer fixed needles in 23G (0.6mm x 25mm), 24G (0.55mm x 25mm), and 25G (0.5mm x 16mm/25mm) configurations with triple-sharpened Japanese stainless steel tubing.
Yes. We offer custom blinded over-wrapping, identical placebo syringes, and unbranded master packs with randomized barcode numbering for double-blind multi-center trials.
A comprehensive B2B buyer guide for international hospital networks, pharmacy chains, and distributors looking to buy sterile disposable syringes wholesale from India with ISO 7886-1 compliance, ultra-transparent barrels, and direct factory-gate pricing.
How humanitarian NGOs, UN agencies, and national tender boards can establish rapid-response medical supply agreements with Indian manufacturers for Interagency Emergency Health Kits (IEHK), sterile consumables, and emergency ICU equipment.
A plain-language guide to the standards that matter when sourcing healthcare products — and how to check them.